Lawrence Baker
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Health Informatics top 5%
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 9
- Healthcare Policy and Management 3
- Pharmaceutical Economics and Policy 3
- Health 7
- Vaccine Coverage and Hesitancy 5
- Co-authors
- John J. Crowley (2 shared papers)KS Albain (1 shared paper)Geoffrey R. Weiss (1 shared paper)C. Harris Spiridonidis (1 shared paper)Agnieszka Woźniak (1 shared paper)David R. Gandara (1 shared paper)R. B. Livingston (1 shared paper)S P Balcerzak (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Alzheimer s & Dementia (1 paper)JAMA Network Open (1 paper)Scientific Reports (1 paper)IEEE Transactions on Intelligent Transportation Systems (1 paper)
- Partner nations
- United StatesUnited KingdomPortugal
In The Last Decade
Lawrence Baker
36 papers receiving 944 citations
Peers
Comparison fields: 5 of 101
- Oncology 561
- Health Informatics 23
- Pulmonary and Respiratory Medicine 538
- Internal Medicine 27
- Modeling and Simulation 33
Countries citing papers authored by Lawrence Baker
This map shows the geographic impact of Lawrence Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Baker more than expected).
Fields of papers citing papers by Lawrence Baker
This network shows the impact of papers produced by Lawrence Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Baker. The network helps show where Lawrence Baker may publish in the future.
Co-authors
The 25 scholars most cited alongside Lawrence Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 462 | |
| 2 | 1990 | 138 | |
| 3 | 1987 | 70 | |
| 4 | 1971 | 63 | |
| 5 | Phase II study of 5-azacytidine in solid tumors. | 1977 | 32 |
| 6 | 2023 | 26 | |
| 7 | 2020 | 21 | |
| 8 | 2021 | 20 | |
| 9 | 2022 | 17 | |
| 10 | 2020 | 17 | |
| 11 | 2022 | 15 | |
| 12 | 2020 | 13 | |
| 13 | 2021 | 12 | |
| 14 | Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study. | 1981 | 12 |
| 15 | 2013 | 11 | |
| 16 | The future of sarcoma treatment. | 1997 | 11 |
| 17 | 2021 | 10 | |
| 18 | Modeling Infectious Behaviors: The Need to Account for Behavioral Adaptation in COVID-19 Models. | 2021 | 6 |
| 19 | 2025 | 5 | |
| 20 | 2024 | 5 |
About Lawrence Baker
Lawrence Baker is a scholar working on Economics and Econometrics, Health, General Health Professions, Modeling and Simulation and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 1.0k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (9 papers), COVID-19 epidemiological studies (6 papers), Vaccine Coverage and Hesitancy (5 papers), Healthcare Policy and Management (3 papers), Lung Cancer Research Studies (3 papers), Pharmaceutical Economics and Policy (3 papers), Diabetes Management and Research (2 papers) and COVID-19 diagnosis using AI (2 papers). The work is most often cited by research in Oncology (561 citations), Health Informatics (23 citations), Pulmonary and Respiratory Medicine (538 citations), Internal Medicine (27 citations) and Modeling and Simulation (33 citations). Lawrence Baker has collaborated with scholars based in United States, United Kingdom and Portugal. Frequent co-authors include John J. Crowley, KS Albain, Geoffrey R. Weiss, C. Harris Spiridonidis, Agnieszka Woźniak, David R. Gandara, R. B. Livingston, S P Balcerzak, Karen Kelly and J. Philip Kuebler. Their work appears in journals such as Journal of Clinical Oncology, Alzheimer s & Dementia, JAMA Network Open, Scientific Reports and IEEE Transactions on Intelligent Transportation Systems.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.